Skip to content

Evaluation of Asymmetrical Lateral Decubitus for Rotation of Occipitoposterior Fetal Position

Evaluation of Asymmetrical Lateral Decubitus for Rotation of Occipitoposterior Fetal Position During Labor : EVADELA Multicentre Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01854450
Acronym
EVADELA
Enrollment
326
Registered
2013-05-15
Start date
2013-05-31
Completion date
2015-05-31
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Occipitoposterior Position During the Labor

Keywords

Occipitoposterior position, Maternal posturing, Labor

Brief summary

Maternal posturing is used during labor to facilitate the rotation of occipitoposterior fetal position in anterior. Our study aims to evaluate the efficacy of asymmetrical lateral decubitus for rotation of the fetal head.

Detailed description

The prevalence of fetal occipitoposterior position during labor is 20%. Compared to anterior positions, they are known to be at higher risk of complications (cesarean section, instrumental delivery, severe perineal laceration). Maternal posturing is used during labor to facilitate the rotation of the fetal head in anterior position. Asymmetrical lateral decubitus is used frequently, without having ever been evaluated. Our study aims to evaluate the efficacy of this maternal posturing, through a randomized open trial. We hypothesized that posturing women in asymmetrical lateral decubitus allows increasing frequency of anterior fetal position after 1 hour.

Interventions

OTHERAsymmetrical Lateral Decubitus

After randomization, women are postured in pronounced lateral decubitus (side opposite to the back of the fetus), with the inferior leg in extension, and the superior leg in hyperflexion, during 1 hour (minimum 30 minutes). Then, women are encouraged to take this posture during labor as frequently as possible if the fetus remains in occipitoposterior position

OTHERcontrol

usual obstetrical care

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women older than 18 years * Gestational age ≥ 37SA, * Ruptured membranes, * single living fetus in cephalic presentation with an occipitoposterior position clinically diagnosed between 2 and 9 cm dilated and confirmed by ultrasound. * Affiliation to a social security scheme (beneficiary or assignee) * Signing the consent

Exclusion criteria

* Fetal presentation other than posterior * Multiple pregnancy, * Breech presentation * History of previous cesarean section * Fetal death in utero, termination of pregnancy * Fetal intrauterine fetal growth restriction \<5e percentile, * Fetal malformation, * Women younger than 18 years old, * Women do not understand French, * Women with psychiatric condition

Design outcomes

Primary

MeasureTime frameDescription
Fetal head position1 hourfetal head position one hour after randomization

Secondary

MeasureTime frameDescription
fetal head positionat diagnosis of full dilatationClinical evaluation of the fetal head position at diagnosis of full cervical dilatation confirmed with ultrasound
Speed of cervical dilatationduring the first stage of labourDuration of labor between randomization and full dilatation
Mode of delivery and perineal complicationsat deliveryMode of delivery (spontaneous vaginal, instrumental vaginal delivery, cesarean section) and perineal complications (episiotomy, severe perineal tears).
feasibility and acceptability of asymmetrical lateral decubitusduring and after labourquality of fetal heart rate monitoring during maternal posturing Evaluation of maternal satisfaction using self-administered questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026